Covered recipient · General Payments record
WILLIAM B CHERRY
Allopathic & Osteopathic Physicians Allergy & Immunology
General Payments · PY2018–2024
$13,802.68
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,000.00 | 1 |
| Food and Beverage | $277.11 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gen-Probe, Inc. | $3,000.00 | 1 |
| GENZYME CORPORATION | $175.98 | 13 |
| iRhythm Technologies, Inc. | $42.17 | 1 |
| Tempus AI, Inc | $28.86 | 1 |
| TOLMAR, INC. | $16.25 | 1 |
| ViiV Healthcare Company | $13.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Gen-Probe, Inc. | $3,000.00 | 03/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1084890551 | CMS |
| GENZYME CORPORATION | $8.34 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139975977 | CMS |
| GENZYME CORPORATION | $7.34 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139975979 | CMS |
| GENZYME CORPORATION | $9.12 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139975987 | CMS |
| GENZYME CORPORATION | $9.00 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139975991 | CMS |
| GENZYME CORPORATION | $12.28 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139975995 | CMS |
| GENZYME CORPORATION | $12.95 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139975999 | CMS |
| GENZYME CORPORATION | $17.35 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976017 | CMS |
| GENZYME CORPORATION | $17.54 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976019 | CMS |
| GENZYME CORPORATION | $16.82 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976023 | CMS |
| GENZYME CORPORATION | $15.71 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976033 | CMS |
| GENZYME CORPORATION | $17.66 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976037 | CMS |
| GENZYME CORPORATION | $14.48 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976045 | CMS |
| GENZYME CORPORATION | $17.39 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139976047 | CMS |
| iRhythm Technologies, Inc. | $42.17 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154055310 | CMS |
| Tempus AI, Inc | $28.86 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150162570 | CMS |
| Tolmar, Inc. | $16.25 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138710762 | CMS |
| ViiV Healthcare Company | $13.85 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112746293 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.